Brief: Abvc Biopharma Executes Cooperation Agreement For Strategic Investments
17/08/2023 13:50
Aug 17 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA INC - EXECUTES COOPERATION AGREEMENT FOR
STRATEGIC INVESTMENTS
* ABVC BIOPHARMA INC- UNDER THE TERMS OF THE COOPERATION
AGREEMENT, THE ESTIMATED VALUE OF THE TRANSACTION IS
APPROXIMATELY $7.4 MILLION
* ABVC BIOPHARMA-ENTERED COOPERATION AGREEMENT TO EXCHANGE
20%
OWNERSHIP STAKE IN REAL ESTATE PROPERTY OF ZHONGHUI UNITED
TECHNOLOGY GROUP,& ITS AFFILIATED ENTERPRISES
* ABVC BIOPHARMA- IN TERMS OF AGREEMENT, ESTIMATED VALUE OF
TRANSACTION IS ABOUT $7.4 MILLION, EQUIVALENT TO 370,000 SHARES
OF CO'S COMMON STOCK AT $20/ SHARE
Source text for Eikon: ID:
Further company coverage: ABVC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon
Brief: Abvc Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: ABVC Biopharma Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements
Brief: ABVC Biopharma Inc On March 5, Leeds Chow Resigns As CFO Of Abvc Biopharma
Brief: ABVC Biopharma Secures $200,000 In First Cash Licensing Payment From Oncology Products Partner